10,652
Total Claims
$1.7M
Drug Cost
1,049
Beneficiaries
$1,653
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
+57%
Cost per patient vs peers
$1,653 vs $1,054 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 9,069 claims · $245K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 525 | $565K |
| Sacubitril/Valsartan | 262 | $265K |
| Evolocumab | 241 | $202K |
| Rivaroxaban | 125 | $143K |
| Empagliflozin | 91 | $121K |
| Alirocumab | 78 | $84K |
| Rosuvastatin Calcium | 810 | $23K |
| Metoprolol Succinate | 979 | $22K |
| Ranolazine | 118 | $18K |
| Ezetimibe | 470 | $17K |
| Semaglutide | 15 | $15K |
| Atorvastatin Calcium | 724 | $13K |
| Eplerenone | 133 | $12K |
| Clopidogrel Bisulfate | 645 | $12K |
| Pitavastatin Calcium | 14 | $12K |
Prescribing Profile
Patient Profile
75
Avg Age
44%
Female
1.67
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About